icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
mVzSdk18z7avkK2F
Listen
